225 related articles for article (PubMed ID: 33692623)
1. Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells.
Zhou Y; Yang Q; Wang F; Zhou Z; Xu J; Cheng S; Cheng Y
Int J Nanomedicine; 2021; 16():1805-1817. PubMed ID: 33692623
[TBL] [Abstract][Full Text] [Related]
2. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
3. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
[TBL] [Abstract][Full Text] [Related]
4. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
5. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
6. Gint4.T-Modified DNA Tetrahedrons Loaded with Doxorubicin Inhibits Glioma Cell Proliferation by Targeting PDGFRβ.
Wang F; Zhou Y; Cheng S; Lou J; Zhang X; He Q; Huang N; Cheng Y
Nanoscale Res Lett; 2020 Jul; 15(1):150. PubMed ID: 32691170
[TBL] [Abstract][Full Text] [Related]
7. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
Liu X; Wu L; Wang L; Jiang W
Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
[TBL] [Abstract][Full Text] [Related]
8. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas.
Li L; Hou J; Liu X; Guo Y; Wu Y; Zhang L; Yang Z
Biomaterials; 2014 Apr; 35(12):3840-50. PubMed ID: 24486214
[TBL] [Abstract][Full Text] [Related]
9. Aptamer-Modified Tetrahedral DNA Nanostructures as Drug Delivery System for Cancer Targeted Therapy.
Zhao R; Bai Y; Guo Y; Feng F; Shuang S
Macromol Biosci; 2024 Apr; 24(4):e2300420. PubMed ID: 38088938
[TBL] [Abstract][Full Text] [Related]
10. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
[TBL] [Abstract][Full Text] [Related]
12. Peptide-like Polymers Exerting Effective Glioma-Targeted siRNA Delivery and Release for Therapeutic Application.
An S; He D; Wagner E; Jiang C
Small; 2015 Oct; 11(38):5142-50. PubMed ID: 26222334
[TBL] [Abstract][Full Text] [Related]
13. Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma.
Sun X; Chen Y; Zhao H; Qiao G; Liu M; Zhang C; Cui D; Ma L
Drug Deliv; 2018 Nov; 25(1):1718-1727. PubMed ID: 30269613
[TBL] [Abstract][Full Text] [Related]
14. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
Bi Y; Zhang Y; Cui C; Ren L; Jiang X
Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
[TBL] [Abstract][Full Text] [Related]
15. Tetrahedral Framework Nucleic Acids Loaded with Aptamer AS1411 for siRNA Delivery and Gene Silencing in Malignant Melanoma.
Xiao D; Li Y; Tian T; Zhang T; Shi S; Lu B; Gao Y; Qin X; Zhang M; Wei W; Lin Y
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6109-6118. PubMed ID: 33497198
[TBL] [Abstract][Full Text] [Related]
16. Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.
Wang Y; Chen X; Tian B; Liu J; Yang L; Zeng L; Chen T; Hong A; Wang X
Theranostics; 2017; 7(5):1360-1372. PubMed ID: 28435471
[TBL] [Abstract][Full Text] [Related]
17. [Apoptosis of glioma cell line U251 induced by small interfering RNA targeting survivin].
Xu RX; Tu YY; Jiang XD; Feng JN; Huang J
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):398-401. PubMed ID: 16624736
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.
Li L; Liu J; Diao Z; Shu D; Guo P; Shen G
Mol Biosyst; 2009 Nov; 5(11):1361-8. PubMed ID: 19823753
[TBL] [Abstract][Full Text] [Related]
19. [Effects of FPR2 gene silencing on the proliferation, migration and invasion of human glioma U87 cells].
Liu L; Li X; Shi J; Li L; Wang J; Luo ZZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):659-666. PubMed ID: 30293389
[No Abstract] [Full Text] [Related]
20. H
Zhou M; Jiang N; Fan J; Fu S; Luo H; Su P; Zhang M; Shi H; Zeng J; Huang Y; Li Y; Shen H; Zhang A; Li R
J Control Release; 2019 Sep; 310():24-35. PubMed ID: 31404556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]